Status:
RECRUITING
Integrated Recovery Program for Critical Illness
Lead Sponsor:
National Taiwan University Hospital
Conditions:
ICU Survivors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate the effects of the Integrated Critical Illness Aftercare and Recovery Enhancement (I-CARE) program on reducing healthcare burden and improving functional outcomes in ICU...
Detailed Description
This randomized clinical trial is designed to evaluate the effectiveness of the Integrated Critical Illness Aftercare and Recovery Enhancement (I-CARE) program for survivors of critical illness discha...
Eligibility Criteria
Inclusion
- ICU survivors who had experienced endotracheal intubation and mechanical ventilation treatment.
Exclusion
- ICU survivors who are unable to walk independently before admission
- ICU survivors who are unable to receive assessment (e.g., dementia or mental retardation)
- ICU survivors who don't have a smartphone.
- ICU survivors were discharged to institutional care facilities
Key Trial Info
Start Date :
November 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06997822
Start Date
November 3 2025
End Date
December 31 2028
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10055